Amneal Pharmaceuticals (AMRX) is recalling three lots of sulfamethoxazole/trimethoprim tablets due to microbial contamination, the US Food and Drug Administration said Wednesday.
The recall was issued after a product quality complaint over the appearance of black spots on the tablet surface, the FDA said.
The lots in question were distributed nationwide to wholesalers and distributors between December 4, 2024 and May 15, 2025, according to the FDA.
The tablets are used for the treatment of urinary tract infections.
Price: 7.41, Change: -0.04, Percent Change: -0.60
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。